VALERIE WATTS: Open Payments
NPI 1962893263 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 40 payments from 14 companies in 2025. Trend: 2023 $67 · 2024 $1,249 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $210 |
| ABBVIE INC. | 14 | $179 |
| Lilly USA, LLC | 5 | $125 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Amgen Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Astellas Pharma US Inc | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| PFIZER INC. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, QULIPTA, UBRELVY, TRELEGY ELLIPTA, JARDIANCE, OTEZLA, Veozah.
Industry payments across MO — which companies pay providers there.
